771 related articles for article (PubMed ID: 34680255)
1. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.
Zhdanovskaya N; Firrincieli M; Lazzari S; Pace E; Scribani Rossi P; Felli MP; Talora C; Screpanti I; Palermo R
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680255
[TBL] [Abstract][Full Text] [Related]
2. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
3. Targeting Notch as a Therapeutic Approach for Human Malignancies.
Platonova N; Lesma E; Basile A; Bignotto M; Garavelli S; Palano MT; Moschini A; Neri A; Colombo M; Chiaramonte R
Curr Pharm Des; 2017; 23(1):108-134. PubMed ID: 27719637
[TBL] [Abstract][Full Text] [Related]
4. Notch and its oncogenic activity in human malignancies.
Brzozowa-Zasada M; Piecuch A; Michalski M; Segiet O; Kurek J; Harabin-Słowińska M; Wojnicz R
Eur Surg; 2017; 49(5):199-209. PubMed ID: 29104587
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of Notch signaling in epidermal differentiation and skin cancer.
Panelos J; Massi D
Cancer Biol Ther; 2009 Nov; 8(21):1986-93. PubMed ID: 19783903
[TBL] [Abstract][Full Text] [Related]
6. The Notch signaling pathway as a mediator of tumor survival.
Capaccione KM; Pine SR
Carcinogenesis; 2013 Jul; 34(7):1420-30. PubMed ID: 23585460
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.
Espinoza I; Pochampally R; Xing F; Watabe K; Miele L
Onco Targets Ther; 2013 Sep; 6():1249-59. PubMed ID: 24043949
[TBL] [Abstract][Full Text] [Related]
8. Study Deciphering the Crucial Involvement of Notch Signaling Pathway in Human Cancers.
Pandey P; Khan F; Singh M; Verma A; Kumar H; Mazumder A; Rakhra G
Endocr Metab Immune Disord Drug Targets; 2023 Nov; ():. PubMed ID: 37997805
[TBL] [Abstract][Full Text] [Related]
9. Notch: a key regulator of tumor angiogenesis and metastasis.
Garcia A; Kandel JJ
Histol Histopathol; 2012 Feb; 27(2):151-6. PubMed ID: 22207549
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targeting of Notch Signaling: From Cancer to Inflammatory Disorders.
Allen F; Maillard I
Front Cell Dev Biol; 2021; 9():649205. PubMed ID: 34124039
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents.
Nickoloff BJ; Osborne BA; Miele L
Oncogene; 2003 Sep; 22(42):6598-608. PubMed ID: 14528285
[TBL] [Abstract][Full Text] [Related]
12. The challenge of targeting notch in hematologic malignancies.
Hernandez Tejada FN; Galvez Silva JR; Zweidler-McKay PA
Front Pediatr; 2014; 2():54. PubMed ID: 24959528
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance.
D'Amico M; De Amicis F
Cancer Drug Resist; 2022; 5(4):939-953. PubMed ID: 36627893
[TBL] [Abstract][Full Text] [Related]
14. Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells.
Shang C; Lang B; Meng LR
Cancer Biol Ther; 2018 Feb; 19(2):113-119. PubMed ID: 27791463
[TBL] [Abstract][Full Text] [Related]
15. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.
Dontu G; Jackson KW; McNicholas E; Kawamura MJ; Abdallah WM; Wicha MS
Breast Cancer Res; 2004; 6(6):R605-15. PubMed ID: 15535842
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into the role of Notch signaling in tumorigenesis.
Leong KG; Karsan A
Blood; 2006 Mar; 107(6):2223-33. PubMed ID: 16291593
[TBL] [Abstract][Full Text] [Related]
17. Notch Signaling in Cancer: Rationale and Strategies for Targeting.
Alketbi A; Attoub S
Curr Cancer Drug Targets; 2015; 15(5):364-74. PubMed ID: 26239151
[TBL] [Abstract][Full Text] [Related]
18. Taming the Notch Transcriptional Regulator for Cancer Therapy.
Tamagnone L; Zacchigna S; Rehman M
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462871
[No Abstract] [Full Text] [Related]
19. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling: its roles and therapeutic potential in hematological malignancies.
Gu Y; Masiero M; Banham AH
Oncotarget; 2016 May; 7(20):29804-23. PubMed ID: 26934331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
